Gene Expression Profiles in Healing and Non-Healing Wounds
NCT01101854 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 74
Last updated 2024-04-25
Summary
The purpose of this study is to develop a database containing information about genes/proteins/fats as well as wound infections in both healing and non-healing wounds. Many wounds that do not heal are infected. This study will help us determine if there is a relationship between the types of infections and how well a wound heals. Identification of genes/proteins/lipids (fats) that help predict wound healing under specific wound healing conditions will enable health care practitioners to select more appropriate treatments, monitor the responses to those treatments, and figure out what standard treatments should be.
Conditions
- Wounds and Injuries
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Gayle Gordillo, MD · Indiana University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-30
- Primary Completion
- 2021-10-23
- Completion
- 2021-10-23
Countries
- United States
Study Locations
More Related Trials
-
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
NCT04252651 ·Status: UNKNOWN
-
Epidermal Coverage of Traumatic Wound Injuries Via Use of Autologous Spray Skin Applied Over Bilayered Wound Matrix
NCT02469168 ·Status: TERMINATED ·Phase: NA
-
Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
NCT05766982 ·Status: WITHDRAWN ·Phase: NA
-
Understanding Coagulation and Inflammation in Burns
NCT03077269 ·Status: TERMINATED
-
Comparison Between the Histological and Clinical Diagnosis of Non Healing Wounds
NCT01230567 ·Status: COMPLETED
-
Split-Thickness Skin Graft Donor Site Wound Healing Study
NCT00392301 ·Status: WITHDRAWN
-
Evaluating MMPs in Burns
NCT03148977 ·Status: TERMINATED
-
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
NCT01858753 ·Status: TERMINATED ·Phase: PHASE2
-
Ultrasound Treatment on Wound Healing Time
NCT05796492 ·Status: TERMINATED ·Phase: NA
-
Autologous Regenerative Technology (ART) For Wound Healing
NCT03368534 ·Status: WITHDRAWN ·Phase: NA
-
Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"
NCT03668665 ·Status: WITHDRAWN ·Phase: PHASE3
-
Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology
NCT05275335 ·Status: RECRUITING
-
Prospective Observation of Wound Healing With Prevena Incision Management System
NCT01704924 ·Status: WITHDRAWN ·Phase: NA
-
A Retrospective Analysis of Patients With Full Thickness Wounds on a Case by Case Basis
NCT00764088 ·Status: COMPLETED
-
The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites
NCT03937765 ·Status: TERMINATED ·Phase: NA
-
Study of the Cutaneous Reinnervation After Burn
NCT02356354 ·Status: TERMINATED ·Phase: NA
-
Gene Expression and Biomarker Profiling of Keloid Skin
NCT03228693 ·Status: COMPLETED ·Phase: NA
-
Identification and Validation of Biomarkers for Infections in Burns
NCT02457663 ·Status: TERMINATED
-
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
NCT00161759 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of the SNaP Wound Care System
NCT01113658 ·Status: WITHDRAWN ·Phase: NA
-
Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis
NCT01858038 ·Status: WITHDRAWN ·Phase: NA
-
The Study on Bacterial Load Following Open-to-air Management in Burn Patients.
NCT04502914 ·Status: WITHDRAWN ·Phase: NA
-
Deep Tissue Injury Treatment With MIST Therapy Versus Standard Care: REVERSE DTI Study
NCT01540981 ·Status: TERMINATED ·Phase: NA
-
Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound
NCT04235296 ·Status: UNKNOWN ·Phase: PHASE1
-
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites
NCT04234750 ·Status: UNKNOWN ·Phase: PHASE1